Sporogenics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $1.6M

  • Investors
  • 2

Sporogenics General Information

Description

Developer of a substance-based medical device intended to provide clinical treatments. The company's products are made from bioactive natural ingredients and are plant-based, which can develop botanical drugs, enabling healthcare professionals to offer medical treatments with natural substances, thereby eliminating the chances of any side effects.

Contact Information

Website
www.sporogenics.com.sg
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 2 Venture Drive
  • Number 24-01, Vision Exchange
  • Singapore, 608526
  • Singapore
+65 8700
Primary Industry
Drug Discovery
Other Industries
Other Devices and Supplies
Biotechnology
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 2 Venture Drive
  • Number 24-01, Vision Exchange
  • Singapore, 608526
  • Singapore
+65 8700

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sporogenics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 28-Nov-2023 $1.6M Completed Generating Revenue
1. Accelerator/Incubator 14-Jul-2020 Completed Generating Revenue
To view Sporogenics’s complete valuation and funding history, request access »

Sporogenics Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Sporogenics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4114479-A1 Adhesion barrier composition, methods of fabrication and use thereof Inactive 02-Mar-2020
EP-4114479-A4 Adhesion barrier composition, methods of fabrication and use thereof Inactive 02-Mar-2020
US-20230095832-A1 Adhesion barrier composition, methods of fabrication and use thereof Inactive 02-Mar-2020
WO-2021177894-A1 Adhesion barrier composition, methods of fabrication and use thereof Inactive 02-Mar-2020 A61L31/005

Sporogenics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Collab Novena Accelerator/Incubator Minority
MedTech Innovator Accelerator/Incubator Minority
To view Sporogenics’s complete investors history, request access »

Ready to get started?

Request a free trial

Sporogenics FAQs

  • When was Sporogenics founded?

    Sporogenics was founded in 2019.

  • Where is Sporogenics headquartered?

    Sporogenics is headquartered in Singapore, Singapore.

  • What industry is Sporogenics in?

    Sporogenics’s primary industry is Drug Discovery.

  • Is Sporogenics a private or public company?

    Sporogenics is a Private company.

  • What is Sporogenics’s current revenue?

    The current revenue for Sporogenics is .

  • How much funding has Sporogenics raised over time?

    Sporogenics has raised $1.6M.

  • Who are Sporogenics’s investors?

    Collab Novena and MedTech Innovator have invested in Sporogenics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process